ArticleScientific reports2021

Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.

Joonas Jukonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.